Brief Report
174 Ann Dermatol
Received January 23, 2019, Revised July 29, 2019, Accepted for publication July 31, 2019
Corresponding author: Myoung-Shin Kim, Department of Dermatology, Sanggye Paik Hospital, Inje University College of Medicine, 1342 Dongil- ro, Nowon-gu, Seoul 01757, Korea. Tel: 82-2-950-1131, Fax: 82-2- 931-8720, E-mail: [email protected]
ORCID: https://orcid.org/0000-0002-0660-8098
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.
org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright © The Korean Dermatological Association and The Korean Society for Investigative Dermatology
CONFLICTS OF INTEREST
The authors have nothing to disclose.
ORCID
YoungHwan Choi, https://orcid.org/0000-0003-4177-7724 Donghwi Jang, https://orcid.org/0000-0002-3495-4772 Hyun Jeong Byun, https://orcid.org/0000-0002-4354-5655 Se Jin Oh, https://orcid.org/0000-0001-7525-4740 Cho Rok Kim, https://orcid.org/0000-0003-4168-4245 Ji-Hye Park, https://orcid.org/0000-0002-6699-5202 Jong Hee Lee, https://orcid.org/0000-0001-8536-1179 Dong-Youn Lee, https://orcid.org/0000-0003-0765-9812
REFERENCES
1. Hong J, Bernstein D. A review of drugs that induce or exacerbate psoriasis. J Psoriasis Psoriatic Arthritis 2012;18:2-11.
2. Kurtulus S, Sakuishi K, Zhang H, Joller N, Tan D, Smyth M, et al. Mechanisms of TIGIT-driven immune suppression in cancer. J Immunother Cancer 2014;2(Suppl 3):O13.
3. Dixon KO, Schorer M, Nevin J, Etminan Y, Amoozgar Z, Kondo T, et al. Functional Anti-TIGIT antibodies regulate development of autoimmunity and antitumor immunity. J Immunol 2018;200:3000-3007.
4. Voudouri D, Nikolaou V, Laschos K, Charpidou A, Soupos N, Triantafyllopoulou I, et al. Anti-PD1/PDL1 induced psoriasis. Curr Probl Cancer 2017;41:407-412.
5. Wang FF, Wang Y, Wang L, Wang TS, Bai YP. TIGIT ex- pression levels on CD4+ T cells are correlated with disease severity in patients with psoriasis. Clin Exp Dermatol 2018;
43:675-682.
https://doi.org/10.5021/ad.2020.32.2.174
Cutaneous Plasmacytosis Showing a Neuronal Involvement in a 35-Year-Old Female
Joong-Heon Suh, Ho-Young Kim, Jae Ho Lee, Soo-Kyung Lee, Un-Ha Lee, Myoung-Shin Kim
Department of Dermatology, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea
Dear Editor:
Cutaneous plasmacytosis (CP) is a rare skin disorder char- acterized by multiple reddish-brown patches and nodules that mainly occur on the trunk in adults1. Histologically, there is a dermal infiltrate of mature plasma cells. We re-
port a case of 35-year-old female who presented with mul- tiple red to brownish macules and patches on the left side of the trunk with a neuronal distribution (Fig. 1). The lesion appeared 4 years ago without any symptoms of pain or itching. A histopathological examination revealed a dense dermal patch-like cellular infiltration surrounding the fol- licles and the nerves (Fig. 2). The infiltrate was composed of lymphocytes, histiocytes, and plasma cells. Immunohis- tochemical staining was positive for CD138, CD3, and CD20. Serum protein electrophoresis and immunoelec- trophoresis revealed polyclonal hypergammaglobulinemia.
Based on these findings, a diagnosis of CP was made. The patient underwent treatment with systemic corticosteroids and narrowband ultraviolet B for 3 months till date. How- ever, the response to the treatment has been minimal.
In our review of the literature, skin manifestations of CP were considerably uniform among patients, with multiple reddish to brownish colored scaly patches, nodules, and
Brief Report
Vol. 32, No. 2, 2020 175 Fig. 1. Multiple red to brownish maculopatches in the left side of the trunk showing a neuronal derma- tosis. We received the patient’s consent form about publishing all photographic materials.
Fig. 2. (A) Lymphoid follicle-like nodular cell infiltrates in the middle and deep dermis intermingled with sparse interstitial cell infiltrates (H&E stain, ×40) (B) Nodules are composed of plasma cells without atypia. Plasma cells are surround- ing the neuron (H&E stain, ×400;
inlet, ×400).
infiltrated plaques. Moreover, they were usually persistent, asymptomatic, or mildly pruritic and were mainly distribut- ed on the chest or back in a symmetrical or “Christmas tree” like pattern, which may require precise differential diag- nosis including pityriasis rosea and small patch para- psoriasis1,2. Several other cases with facial or scalp in- volvement demonstrated a typical trunk involvement pat- tern as well2. Interestingly, in our patient, the distribution of the lesion showed an atypical pattern, affecting only the left side of the body and showing neuronal pattern dermatoses.
The histopathologic findings characteristically show der- mal nodular and perivascular/periadnexal cell infiltrations with predominance of plasma cells admixed with variable numbers of lymphocytes and histiocytes3. Recently, Honda et al.3 reported 6 cases of CP all showing the perineural
and intraneural distribution of plasma cells. Similarly, in our patient’s punch biopsy specimen, we observed peri- neural plasma cell infiltration. In this case, we hypothesize that the numerous plasma cells aggregated around the nerve fiber may have a correlation with the unilaterally neuronal pattern of the skin lesions. Furthermore, the typi- cal symmetric pattern of CP on the chest or back may be a phenotypic expression reflecting its close relationship to the spinal nerve tract distribution.
Protein electrophoresis and immunoelectrophoresis gen- erally show polyclonal increase in the gamma globulin fraction in major portion (84%) of the CP patients2. However, the direct relationship between polyclonality and etiology of CP is unclear. If monoclonality is ob- served, it is necessary to exclude the possibility of margin- al zone B cell lymphoma. Polymerase chain reaction for
Brief Report
176 Ann Dermatol
Received March 18, 2019, Revised July 23, 2019, Accepted for publication August 7, 2019
Corresponding author: Sung-Ae Kim, Department of Dermatology, Keimyung University School of Medicine, 56 Dalseong-ro, Jung-gu, Daegu 41931, Korea. Tel:
82-53-250-7624, Fax: 82-53-250-7626, E-mail: skksasf@ hanmail.net ORCID: https://orcid.org/0000-0002-6040-6630
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons. org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright © The Korean Dermatological Association and The Korean Society for Investigative Dermatology
immunoglobulin heavy chain gene rearrangement and B-cell lymphoma 2 staining would be helpful to make the diagnosis clear4.
In summary, a diagnosis of CP should be considered when dermatologists encounter cases of asymptomatic neuronal pigment dermatosis. We speculate that further investiga- tions on the association of the neural pathway with re- spect to the pathophysiology would be helpful to improve our understanding about CP.
CONFLICTS OF INTEREST
The authors have nothing to disclose.
ORCID
Joong-Heon Suh, https://orcid.org/0000-0002-1046-0487 Ho-Young Kim, https://orcid.org/0000-0002-1029-3287 Jae Ho Lee, https://orcid.org/0000-0002-3872-0527 Soo-Kyung Lee, https://orcid.org/0000-0002-7460-5657
Un-Ha Lee, https://orcid.org/0000-0003-1626-5583 Myoung-Shin Kim, https://orcid.org/0000-0002-0660-8098
REFERENCES
1. Uhara H, Saida T, Ikegawa S, Yamazaki Y, Mikoshiba H, Nijoh S, et al. Primary cutaneous plasmacytosis: report of three cases and review of the literature. Dermatology 1994;
189:251-255.
2. Haque M, Hou JS, Hisamichi K, Tamada K, Cusack CA, Abdelmalek M, et al. Cutaneous and systemic plasmacytosis vs. cutaneous plasmacytic castleman disease: review and speculations about pathogenesis. Clin Lymphoma Myeloma Leuk 2011;11:453-461.
3. Honda R, Cerroni L, Tanikawa A, Ebihara T, Amagai M, Ishiko A. Cutaneous plasmacytosis: report of 6 cases with or without systemic involvement. J Am Acad Dermatol 2013;68:978-985.
4. Han XD, Lee SSJ, Tan SH, Chong WS, Ng SK, Ooi MGM, et al. Cutaneous plasmacytosis: a clinicopathologic study of a series of cases and their treatment outcomes. Am J Dermatopathol 2018;40:36-42.
https://doi.org/10.5021/ad.2020.32.2.176
Expression of Human Herpes Virus 6, 7, Epstein-Barr Virus and Cytomegalovirus in Patients with Diverse Adverse Cutaneous Reactions to Drug
Young-Wook Ryoo, Joon-Bum Lee, Won-Oh Kim, Sung-Ae Kim
Department of Dermatology, Keimyung University School of Medicine, Daegu, Korea
Dear Editor:
Various drugs can cause diverse cutaneous adverse drug reactions (CADR)1. Factors have been implicated in CADR, including the dosage, duration of use, physiological status
and genetic background of the patient1. In addition, cur- rent or past viral infection has been reported to affect the occurrence of CADR2. In particular, many authors have suggested the activation of human herpes virus (HHV) 6,